2,4-Dinitrophenol, or DNP, is an industrial chemical that was proposed as an obesity drug in the early 1930s because it dramatically raises metabolic rate, then withdrawn after it caused liver failure and death
The risk of bias was graded as low, unclear or high via a systematic assessment on five domains: randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome and selection of the reported result
Our approach combines prescription medications with nutritional counseling, metabolic optimization, and ongoing support to ensure long-lasting results
Supplied as lyophilised powder, third-party tested, with the batch certificate published on this page